News Opinion Conversations in Cardiology Conversations in Cardiology: ISCHEMIA’s Lasting Fallout December 29, 2022
News Daily News FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil Michael O'Riordan December 14, 2022
News Industry News Corvia Medical Announces Randomization of First Patient in the RESPONDER-HF Confirmatory Trial December 06, 2022
News Conference News PCR London Valves 2022 Big Gains in Function, QoL With Transcatheter TV Replacement: TRISCEND Registry Shelley Wood November 28, 2022
News Daily News Sodium Restriction No Help, No Harm in HF, Meta-analysis Confirms Shelley Wood November 23, 2022
News Conference News AHA 2022 Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI L.A. McKeown November 07, 2022
News Conference News HFSA 2022 REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status L.A. McKeown October 07, 2022
News Conference News TCT 2022 Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year L.A. McKeown September 23, 2022
News Conference News TCT 2022 TRILUMINATE Pivotal Trial: First Data Support Safety, Efficacy of TriClip Caitlin E. Cox September 17, 2022
News Conference News ESC Heart Failure 2022 Dapagliflozin Boosts Health Status Across LVEF Range Shelley Wood May 23, 2022
News Conference News ACC 2022 No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3 Michael O'Riordan April 13, 2022
News Conference News ACC 2022 QoL Gains Within 15 Days in Acute HF With Empagliflozin: EMPULSE Analysis L.A. McKeown April 07, 2022
News Conference News ACC 2022 Better Angina Relief With Complete PCI in STEMI and MVD L.A. McKeown April 02, 2022
News Conference News ACC 2022 SODIUM-HF: No Impact of Tighter Dietary Salt Restriction on Death or Hospitalization L.A. McKeown April 02, 2022
News Conference News THT 2022 Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size Shelley Wood February 02, 2022
News Daily News Before and After PCI, Women Have Poorer Health Status Than Men L.A. McKeown January 28, 2022
News Conference News AHA 2021 Empagliflozin Safe in Acute HF, Improves ‘Clinical Benefit’ Over Time: EMPULSE Shelley Wood November 14, 2021
News Conference News ESC 2021 FFR During Angiogram Not Beneficial in Chest Pain Patients: RIPCORD 2 Michael O'Riordan August 29, 2021